Based on the key roles of CENPA and SFN in LIHC progression, future studies can further explore the molecular regulatory network of these two genes in LIHC pathogenesis, study their functions in the tumor microenvironment, and evaluate their application value in personalized treatment. The gene discussed is CENPA; the disease is neoplasm.